Brief: Ampio Pharmaceuticals Inc Receives Approval From The Drugs Controller General Of India (DCGI) To Commence AP-019 Phase II Study In India
21/09/2021 14:17
Sept 21 (Reuters) - Ampio Pharmaceuticals Inc AMPE.A :
* AMPIO PHARMACEUTICALS RECEIVES APPROVAL FROM THE DRUGS
CONTROLLER GENERAL OF INDIA (DCGI) TO COMMENCE AP-019 PHASE II
STUDY IN INDIA
Source text for Eikon: ID:nPn7fFkTGa
Further company coverage: AMPE.A
Recent news on Ampio Pharmaceuticals
See all newsBrief: Ampio Announces Voluntary Delisting And SEC Deregistration
Brief: Ampio Provides Update On Results From Pre-IND Enabling Studies
Brief: Ampio Selects Ascendia Pharmaceuticals, Inc. To Provide CDMO Services To Support Clinical Development Of OA-201
Brief: Ampio Pharmaceuticals Announces Reverse Stock Split
Brief: Ampio Pharmaceuticals Inc - Holds Approximately $1.25 Million In A Deposit Account At Silicon Valley Bank